中国药业2017，Vol.26Issue(10)：89-91,3.DOI:10.3969/j.issn.1006-4931.2017.10.026
某院2013年至2015年慢性乙型肝炎抗病毒药物应用分析
Application of Antiviral Drugs for Hepatitis B in a Hospital from 2013 to 2015
李峙臻 1汪时斋2
作者信息
- 1. 四川省攀枝花市第四人民医院药械科,四川攀枝花 617061
- 2. 中国人民解放军南京军区联勤部鹰潭离职干部休养所,江西鹰潭 335000
- 折叠
摘要
Abstract
Objective To investigate the application and trend of antiviral drugs for hepaitis B in the hospital from 2013 to 2015. Methods The total sales amount,DDDs,DDC of the antiviral drugs for hepaitis B in our hospital from 2013 to 2015 were ana-lyzed statistically. Results The sales amount of antiviral drugs for hepaitis B increased annually. Among the 3 years,the usage amount of Entecavir increased rapidly,and both the sale amount and DDDs ranked the first place,the Adefovir Tablet ranked next. The sales amount of interferon did not change significantly. Conclusion Necleoside analogues takes the dominant place in clinical use among the antiviral drugs for hepaitis B,but clinicians preferred to use Entecavir. For the long time of nucleoside analogues or combined use,the drug tolerance to hepatitis B virus and the adverse reactions should be monitored to achieve the aim of differentiated treatment method for individuals.关键词
慢性乙型肝炎/乙型肝炎病毒/抗病毒药物/恩替卡韦Key words
chronic hepatitis B/hepatitis B virus/Antiviral drugs/Entecavir分类
医药卫生引用本文复制引用
李峙臻,汪时斋..某院2013年至2015年慢性乙型肝炎抗病毒药物应用分析[J].中国药业,2017,26(10):89-91,3.
